- EffiX™ is designed to meet the industry's demand for a high-yield, stable, and non-lysogenic E. coli expression system. It serves as a comprehensive solution for the development and manufacturing of ...

Key market opportunities in the global competent cells market include rising demands in genetic engineering and synthetic ...

Recombinant antibodies (rAbs), also called genetically engineered antibodies, are produced by cloning the antibody which is made of light and heavy chain DNA sequences. In comparison to monoclonal ...

The concept of a ‘plasmid’ was first introduced by Joshua Lederberg in 1952. Since that time, it has become widely recognized as a circular DNA able to viably function as a carrier for introducing a ...

Expressing recombinant proteins is one of the most challenging, but at the same time most important tasks in the life sciences. Irrespective of the specific protein and the downstream applications, ...

For cell-cultured meat to go mainstream, the cost of the media used to grow animal cells must come down. A lot. And that will require significant movement in the price and availability of recombinant ...

Right now, the pricier components of growth media – the nutrient-rich broth used to feed cells that will turn into cultivated meat – are typically produced by armies of microbes engineered to churn ...

- EffiX™ is designed to meet the industry's demand for a high-yield, stable, and non-lysogenic E. coli expression system. It serves as a comprehensive solution for the development and manufacturing of ...